CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+12.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.6B
AUM Growth
+$15.6B
(+7.9%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
755
New
44
Increased
354
Reduced
220
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
$80.1M |
| 2 |
Salesforce
CRM
|
$55.1M |
| 3 |
Micron Technology
MU
|
$53.8M |
| 4 |
Apple
AAPL
|
$50M |
| 5 |
Applied Materials
AMAT
|
$48.3M |
Top Sells
| 1 |
Merck
MRK
|
$73.5M |
| 2 |
ANSS
Ansys
ANSS
|
$53.4M |
| 3 |
Adobe
ADBE
|
$51.7M |
| 4 |
TJX Companies
TJX
|
$41.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
$39.6M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 28.37% |
| 3 | Financials | 8.73% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Bank of New York Mellon
BK
$73.8B
| $45M | 0.29% |
780,731
-26,033
| -3% | -$1.5M |
|
77
AbbVie
ABBV
$374B
| $44.5M | 0.28% |
244,486
+23,834
| +11% | +$4.34M |
|
78
Air Products & Chemicals
APD
$64.8B
| $44.3M | 0.28% |
182,766
-35,836
| -16% | -$8.68M |
|
79
NextEra Energy, Inc.
NEE
$148B
| $43.8M | 0.28% |
684,785
-146,771
| -18% | -$9.38M |
|
80
Neurocrine Biosciences
NBIX
$13.5B
| $43.5M | 0.28% |
315,684
-54,215
| -15% | -$7.48M |
|
81
Johnson & Johnson
JNJ
$429B
| $43.3M | 0.28% |
273,499
-33,731
| -11% | -$5.34M |
|
82
Keros Therapeutics
KROS
$640M
| $43.2M | 0.28% |
651,999
-167,063
| -20% | -$11.1M |
|
83
American Water Works
AWK
$27.5B
| $42.9M | 0.27% |
351,390
-115,296
| -25% | -$14.1M |
|
84
McDonald's
MCD
$226B
| $42.7M | 0.27% |
151,621
-47,221
| -24% | -$13.3M |
|
85
Progressive
PGR
$145B
| $42.3M | 0.27% |
204,708
+58,128
| +40% | +$12M |
|
86
Elevance Health
ELV
$72.4B
| $41.1M | 0.26% |
79,355
+29,267
| +58% | +$15.2M |
|
|
87
TJX Companies
TJX
$155B
| $41M | 0.26% |
403,790
-407,981
| -50% | -$41.4M |
|
88
Schlumberger
SLB
$52.2B
| $40.7M | 0.26% |
742,968
+70,483
| +10% | +$3.86M |
|
89
Intel
INTC
$105B
| $40.7M | 0.26% |
921,793
+299,091
| +48% | +$13.2M |
|
90
Vipshop
VIPS
$8.36B
| $40.6M | 0.26% |
2,109,751
-1,121,600
| -35% | -$21.6M |
|
91
Estee Lauder
EL
$33.1B
| $40.2M | 0.26% |
260,784
+106,630
| +69% | +$16.4M |
|
92
Bristol-Myers Squibb
BMY
$96.7B
| $39.6M | 0.25% |
730,126
+131,449
| +22% | +$7.13M |
|
93
Ionis Pharmaceuticals
IONS
$9.64B
| $39.5M | 0.25% |
911,897
+282,830
| +45% | +$12.3M |
|
94
Cintas
CTAS
$82.9B
| $38.9M | 0.25% |
226,216
+30,716
| +16% | +$5.28M |
|
95
Automatic Data Processing
ADP
$121B
| $38.3M | 0.25% |
153,429
-72,547
| -32% | -$18.1M |
|
96
Mondelez International
MDLZ
$79.3B
| $37.6M | 0.24% |
537,288
-51,088
| -9% | -$3.58M |
|
|
ALTR
97
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $37.5M | 0.24% |
+434,749
| New | +$37.5M |
|
98
Parker-Hannifin
PH
$94.8B
| $37.1M | 0.24% |
66,789
-849
| -1% | -$472K |
|
99
Synopsys
SNPS
$110B
| $37.1M | 0.24% |
64,880
-22,798
| -26% | -$13M |
|
100
Pfizer
PFE
$141B
| $36.3M | 0.23% |
1,308,162
+426,371
| +48% | +$11.8M |
|